COCRYSTAL PHARMA, INC. Cash Equivalents, at Carrying Value
COCRYSTAL PHARMA, INC. (COCP) had Cash Equivalents, at Carrying Value of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-31
- 2025-12-31: Cash Equivalents, at Carrying Value $0.00.
- 2024-12-31: Cash Equivalents, at Carrying Value $0.00.
- 2023-12-31: Cash Equivalents, at Carrying Value $0.00.
- 2022-12-31: Cash Equivalents, at Carrying Value $0.00.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-29 | |
| 2021-09-30 | $61.58M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-23 | $33.01M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |